Establishes under the direction of the state board of pharmacy a drug repository program to accept and dispense donated prescription drugs; authorizes such board and the commissioner of health to promulgate rules and regulations; makes definitions; exempts such persons or entities who dispense such donated drugs from criminal or tort liability or professional disciplinary action.
S07373 would create a statewide prescription drug repository program under the State Board of Pharmacy. The program would allow donated prescription drugs to be collected at participating pharmacies, hospitals, and nonprofit clinics, then dispensed to eligible New York residents who meet standards set by regulation. The bill limits what can be accepted: drugs must generally be in original sealed, tamper-evident unit-dose packaging, must not be close to expiration, and must not be adulterated. It also excludes certain drugs that are subject to special federal distribution restrictions, such as drugs that can only be dispensed to patients registered with the manufacturer.
The bill authorizes donations from individuals, health care facilities, drug manufacturers, and government entities, and it allows unused Medicaid-dispensed prescription drugs to be accepted if they meet the program’s requirements. Participating entities would be allowed to charge a handling fee to cover storage and dispensing costs, but donated drugs could not be resold. The State Board of Pharmacy, in consultation with the Commissioner of Health, would be required to adopt detailed rules covering eligibility, storage, inspection, donor forms, recipient eligibility, and fee calculations.
The bill would add a new section to the Education Law establishing a drug repository framework and giving the State Board of Pharmacy regulatory authority over the program. It would also create liability protections for the state, participating pharmacies, hospitals, nonprofit clinics, health care professionals, donors, and drug manufacturers for actions taken in good faith under the program, including protection from criminal prosecution, civil liability, and professional discipline. In practice, the measure would expand access to prescription medications for low-income or uninsured residents while imposing state-level standards for safety, eligibility, and handling.
Based on the bill text and available context, the measure appears generally favorable and public-interest oriented, with an emphasis on reducing waste and improving access to medications for residents with economic need. The bill is structured to encourage participation by making the program voluntary and by providing broad immunity protections to reduce legal risk for donors and dispensing entities. No committee transcript or vote record was provided, so there is no documented opposition or recorded floor sentiment in the available materials.
The main policy tensions are likely to center on patient safety, regulatory burden, and liability. Critics could question whether donated drugs can be reliably screened, stored, and tracked, especially given the limits on inspection and the possibility of handling drugs previously dispensed through Medicaid. Others may focus on whether the handling fee is sufficient to cover administrative costs or whether the program could create operational burdens for pharmacies, hospitals, and nonprofit clinics. The bill addresses these concerns by requiring sealed tamper-evident packaging, excluding certain drugs, mandating inspection and rulemaking, and making participation voluntary.